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Mechanisms that regulate progenitor cell quiescence
and differentiation in slowly replacing tissues are not
fully understood. Here, we demonstrate that the tu-
mor suppressor p53 regulates both proliferation and
differentiation of progenitors in the airway epithelium.
p53 loss decreased ciliated cell differentiation and
increased the self-renewal and proliferative capacity
of club progenitors, increasing epithelial cell density.
p53-deficient progenitors generated a pseudostrati-
fied epithelium containing basal-like cells in vitro
and putative bronchioalveolar stem cells in vivo.
Conversely, an additional copy of p53 increased
quiescence and ciliated cell differentiation, high-
lighting the importance of tight regulation of p53
levels. Using single-cell RNA sequencing, we found
that loss of p53 altered the molecular phenotype of
progenitors and differentially modulated cell-cycle
regulatory genes. Together, these findings reveal
that p53 is an essential regulator of progenitor cell
behavior, which shapes our understanding of stem
cell quiescence during homeostasis and in cancer
development.INTRODUCTION
Epithelial tissues consist of closely packed functional cells that
are replaced by resident stem or progenitor populations at rates
that vary between tissues. Here, we investigate how these
progenitor cells are regulated in a slowly replacing tissue, the
airway epithelium of the lung. The mammalian airway epithelium
varies in composition between species and according to airway
location. Intralobar-conducting bronchi and bronchioles of the
mouse lung are composed of secretory and ciliated cells. Tight
control over the proportions and abundance of these cell types
is essential for effective mucociliary clearance of inhaled par-
ticulates and microorganisms.
Club cells, previously known as Clara cells, are secretory cells
that express the protein Scgb1a1 (also known as CCSP or CC10)Cell Repor
This is an open access article under the CC BY-N(Rackley and Stripp, 2012). They function as regional progenitors
due to their ability to self-renew and differentiate into ciliated cells
(Hogan et al., 2014). Club cells have a low level of turnover during
homeostasis, yet how this quiescence is maintained is still poorly
understood (Rawlins et al., 2009). Developmentally important
pathways, such as Wnt, BMP, Notch, JAK/STAT, and Hippo/
Yap, have been shown to regulate various populations of lung
stem and progenitor cells, directly influencing epithelial composi-
tion (Hogan et al., 2014). However, very few studies have identi-
fied novel integrators of these pathways that control the critical
balance between progenitor cell renewal and differentiation.
Trp53 (p53) is a tumor suppressor and one of the most
commonly mutated genes in cancer (Kandoth et al., 2013). Germ-
line loss of p53 leads to Li-Fraumeni syndrome, a cancer predis-
position disorder, and somatic mutations in p53 are clinically
associatedwith shortened survival time (Malkin, 2011). In addition
to its classical functions in regulating cell fate following cellular
stress, there is growing evidence that p53 regulates progenitor
cells in a variety of developing and adult tissues (Armesilla-Diaz
et al., 2009; Cicalese et al., 2009; Li et al., 2015; Liu et al., 2009;
Meletis et al., 2006; Tosoni et al., 2015). These studies highlight
an essential role for p53 using rapidly dividing models. However,
it is not clear what role, if any, p53 plays in regulating progenitor
cell behavior in a quiescent tissue, such as the lung.
Here, we show that p53 regulates the composition of postnatal
airwayepitheliumbymaintainingquiescenceand regulatingdiffer-
entiation of resident progenitor cells during homeostasis. Genetic
manipulation of p53 copy number altered both the density and the
cellular composition of the airway epithelium. Furthermore, p53
regulated the multipotency of club progenitors. Using single-cell
RNAsequencing (RNA-seq),wediscovered that p53 losschanges
the proportions of subtypes of cells and alters expression of cell-
cycle regulators. Together, our findings reveal key roles for p53
in the homeostatic regulation of airway epithelial progenitor cells.
RESULTS
p53 Regulates Proliferation and Cell Death In Vitro
To examine the contribution of p53 in regulating club progenitor
cells, we used a loss-of-function model coupled with lineage
tracing to assess in vitro clonogenic potential. Scgb1a1-
CreERTM; Rosa26-mT/mG mice with either a wild-type orts 17, 2173–2182, November 22, 2016 ª 2016 The Author(s). 2173
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(A) Fluorescent images of GFP+ passage 0 (P0)
after 7 days in culture. Cells were isolated from
Scgb1a1-CreERTM; Rosa26-mT/mG; p53+/+ or
p53D/ mice.
(B) Colony-forming efficiency (percentage of
colonies of total number of cells seeded) at P0
(n = 34 mice).
(C) Fluorescent images of GFP+ colonies after
7 days in culture at passages 1 and 4. Cells were
isolated from Scgb1a1-CreERTM; Rosa26-mT/mG;
p53+/+ or p53D/ mice.
(D) Colony-forming efficiency at various passages
(n = 3 mice).
(E) Immunofluorescent (IF) staining for GFP-lineage
tag and IdU. Arrowheads indicate IdU+ cells; a
dashed line is shown at the basement membrane.
Analysis was performed in Scgb1a1-CreERTM;
Rosa26-mT/mG; p53+/+ or p53D/D mice.
(F) Percentage of IdU-positive GFP-lineage-tagged
cells (n = 4–5 mice).
(G) Percentage of isolated epithelial cells from
Scgb1a1-CreERTM; p53D/Dmice in G2/M relative to
wild-type control (ctrl) as indicated by propidium
iodide (PI) staining (n = 3–5 mice). TMX, tamoxifen.
(H) Percentage of isolated epithelial cells from
Super p53 mice in G2/M relative to wild-type con-
trol, as indicated by propidium iodide (PI) staining
(n = 3 mice).
Scale bars represent 1 mm in (A) and (C) and 10 mm
in (E). *p < 0.05; **p < 0.01; ***p < 0.001; ****p <
0.0001. All data shown represent mean ± SEM.
See also Figures S1 and S2.p53flox/ allele were used. All cells in the body of Scgb1a1-
CreERTM; Rosa26-mT/mG; p53flox/ mice are heterozygous for
p53. Upon tamoxifen injection, the loxP sites around the remain-
ing p53 allele (indicated by p53flox) are recombined, yielding club
cells that are deficient for p53 (p53D/) and are genetically line-
age tagged with GFP. Control Scgb1a1-CreERTM; Rosa26-mT/
mG; p53+/+ tamoxifen-treated mice are sufficient for p532174 Cell Reports 17, 2173–2182, November 22, 2016(p53+/+) and express GFP in club cells.
Lineage-tagged GFP+ club progenitors
were sorted and co-cultured with p53-
sufficient fibroblasts in a 3D Matrigel cul-
ture system (Figure S1A). After 7 days,
p53-deficient cells generated significantly
more colonies than p53-sufficient cells
(Figures 1A and 1B). Additionally, p53-
deficient cells generated significantly
more colonies across multiple passages
(Figures 1C and 1D). Considering that
p53 is a well-known regulator of cell pro-
liferation and survival, we assessed the
impact of altered p53 status on colony-
forming ability in vitro. p53 loss resulted
in significantly more Ki67-positive line-
age-tagged cells (Figures S1B and S1C).
Additionally, we found significantly fewer
cleaved-caspase-3-positive apoptoticcells in cultures of p53-deficient cells (Figures S1D and S1E).
Furthermore, using flow cytometry at the time of passage, we
detected significantly more lineage-tagged cells staining posi-
tive for 7AAD, a DNA-binding dye that identifies dead cells, in
p53-sufficient cultures than in p53-deficient cultures at late
passages (Figures S1F and S1G). These results suggest that
p53 inhibits progenitor cell proliferation and survival in vitro.
p53 Maintains Quiescence of Club Cells In Vivo
Wenext sought to determinewhether altering the p53 level would
affect epithelial proliferation in vivo in a normally quiescent tissue
such as the lung. FACS (fluorescence-activated cell sorting)-en-
riched total epithelial cells from tamoxifen-treated Scgb1a1-
CreERTM; p53flox/flox mice (p53D/D mice) and wild-type controls
were stainedwithpropidium iodideandanalyzed forDNAcontent
to measure cell-cycle phase via flow cytometry (Figure S1H).
p53-deficient mice had significantly more epithelial cells in G2/
M at 3 days following tamoxifen exposure compared to p53-suf-
ficient controls (Figure 1G). No change in proliferation existed in
non-tamoxifen-treated p53D/D mice (Figure S1I). Additionally,
Scgb1a1-CreERTM; Rosa26-mT/mG; p53+/+ or p53flox/flox mice
were treated with a single dose of tamoxifen and then were given
iododeoxyuridine (IdU) drinking water for 7 days to assess pro-
liferation. p53-deficient mice had significantly more GFP-posi-
tive-lineage-labeled cells that incorporated IdU as compared to
controls, further supporting the idea that p53 inhibits proliferation
in a cell-autonomous manner in vivo (Figures 1E and 1F).
We also assessed cell cycle in mice carrying one transgenic
p53 allele in addition to the two endogenous alleles, referred to
as ‘‘Super p53’’ mice (Garcı´a-Cao et al., 2002). In contrast to
our findings with p53-deficient mice, Super p53 mice with three
copies of p53 had significantly fewer epithelial cells in G2/M
compared to p53+/+ controls (Figure 1H). These findings were
further reinforced when bromodeoxyuridine (BrdU) incorporation
was used to measure proliferation. Flow cytometry for BrdU re-
vealed that Super p53 mice had significantly fewer proliferating
cells compared to control (Figure S1J). Together, these results
indicate that altering p53 copy number tightly regulates quies-
cence of epithelial progenitor cells in the homeostatic airway.
Airway Epithelial Cell Density Is Regulated by p53 in a
Dose-Dependent Manner
Considering that p53 gene dose regulates proliferation in the
airway epithelium, we next sought to determine whether altered
proliferation led to changes in cell density. To test this, we
used Scgb1a1-CreERTM; Rosa26R-Confetti; p53+/+, p53flox/,
or p53flox/flox mice (p53+/+, p53D/, or p53D/Dmice, respectively).
Tamoxifen exposure in these mice induces recombination at the
Confetti allele (specifically in club cells), which genetically tags all
club cells and their progeny (lineage tag) with either nuclear GFP,
cytoplasmic YFP (yellow fluorescent protein), membrane CFP
(cyan fluorescent protein), or cytoplasmic RFP (red fluorescent
protein). GFP-, YFP-, and CFP-lineage-labeled cells were identi-
fied by a GFP antibody, and RFP-lineage-labeled cells were
identified by an RFP antibody. Cell density was determined by
quantifying the number of lineage-tagged cells per unit base-
ment membrane at 2, 30, and 70 days post-tamoxifen exposure.
p53 loss significantly increased the number of lineage-tagged
cells per unit basement membrane compared to p53-sufficient
controls (Figures 2A and 2B). Additionally, total cell density
along the airway epithelium was significantly increased in
p53D/ and p53D/D mice (Figures S1K and S1L). Similar findings
were observed using whole-mount imaging, in which p53 loss
significantly increased both the number of lineage-labeled
patches per unit area and the total airway epithelial cell density
(Figures 2D–2G and S1M). Next, we assessed the number ofconfetti-lineage-tagged cells per unit basement membrane in
Scgb1a1-CreERTM; Rosa26R-Confetti; Super p53 mice at
70 days post-tamoxifen. Super p53 mice had significantly fewer
lineage-tagged cells per unit basement membrane, as well as
significantly fewer nuclei per unit area compared to wild-type
controls (Figures 2C, 2F, and 2G). Taken together, these data
demonstrate that p53 copy number determines the density of
airway epithelial cells during homeostasis.
p53 Levels InfluenceClonal Behavior of Progenitor Cells
To assess the ability of a single progenitor cell to clonally expand,
we administered a low dose of tamoxifen (1 3 5 mg/kg) to
Scgb1a1-CreERTM; Rosa26R-Confetti; p53+/+ or p53flox/flox mice,
referred to as p53+/+ or p53D/D mice, and quantified the size of
GFP, RFP, or YFP patches. p53 loss resulted in a significant in-
crease in the percentage of clones containing three or more cells
compared to control (Figures S2A and S2B). Additionally the
number of cells per patch was significantly increased, with p53-
deficient cells generating patches twice as large as that in control
(Figure S2C). Scgb1a1-CreERTM; Rosa26R-Confetti; Super p53
mice had a significant decrease in the number of cells per patch,
indicating that tight control over p53 levels is essential to maintain
correct progenitor pool size (Figures S2D–S2G).
p53 Regulates Differentiation of Club Progenitor Cells
Given that club cells generate ciliated cells, we tested the hy-
pothesis that p53 regulates club to ciliated cell differentiation in
the airway epithelium. To do this, we assessed the number of
lineage-tagged ciliated cells, indicated by FoxJ1 staining,
following tamoxifen exposure in Scgb1a1-CreERTM; Rosa26R-
Confetti; p53+/+, p53flox/, or p53flox/flox mice (p53+/+, p53D/, or
p53D/D mice, respectively). Loss of p53 in club cells led to the
generation of significantly fewer ciliated cells as compared to
control (Figures 3A and 3B; Figures S3A and S3B). To test
whether increasing the p53 gene dose would influence ciliated
cell differentiation, we quantified the number of FoxJ1+ cells in
the airway epithelium of Super p53 mice and found significantly
more ciliated cells compared to controls (Figures 3C and S3C).
Conversely, we found that p53 loss led to an increase in club
cell generation, while an extra copy of p53 decreased club cell
numbers (Figures 3D and 3E). These results demonstrate that
the number of p53 gene copies directly regulates club-to-ciliated
cell differentiation in vivo.
p53 Loss of Function Alters Differentiation Potential
We hypothesized that p53 loss might also affect differentiation
in vitro. Cultures were stained for markers of various airway cell
types, including p63 and keratin 5 (K5), which traditionally mark
basal cells, a stem cell population located in the trachea and
proximal conducting airway of mice. Basal cells are not derived
from Scgb1a1-expressing cells under homeostatic conditions
in the postnatal mouse. Surprisingly, culture of lineage-labeled
GFP+ cells from tamoxifen-treated Scgb1a1-CreERTM; Rosa26-
mT/mG; p53flox/ mice yielded organoids composed of a pseu-
dostratified epithelium containing a significant number of ciliated
cells, marked by a-tubulin, as well as p63-and K5-positive line-
age-tagged basal-like cells (Figures 3F–3K and S3D–S3F). This
indicates that an Scgb1a1-expressing progenitor was able toCell Reports 17, 2173–2182, November 22, 2016 2175
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Figure 2. p53 Regulates Epithelial Density
(A) Immunofluorescent (IF) staining for confetti-lineage
tag (nuclear GFP, cytoplasmic YFP, and membrane
CFP are indicated in green, and cytoplasmic RFP is
indicated in red) and DAPI in blue in Scgb1a1-
CreERTM; Rosa26R-Confetti; p53+/+, p53D/, or Super
p53 mice 70 days post-tamoxifen.
(B) Quantification of the number of lineage-tagged
cells per unit basement membrane (BM) in Scgb1a1-
CreERTM; Rosa26R-Confetti; p53D/ or p53D/D mice
(p53D/ or p53D/D, respectively) at 2, 30, and 70 days
post-tamoxifen (post-TMX) (n = 3–4).
(C) Quantification of the number of lineage-tagged
cells per unit basement membrane in Scgb1a1-
CreERTM; Rosa26R-Confetti; Super p53 mice at
70 days post-tamoxifen (n = 3).
(D) Whole-mount image of native confetti fluorescence
in Scgb1a1-CreERTM; Rosa26R-Confetti; p53+/+ or
p53D/D mice at 70 days after 600 mg/kg tamoxifen.
(E) Quantification of the number of YFP patches
per unit area at 70 days after 600 mg/kg tamoxifen
(n = 4–5).
(F) Whole-mount DAPI staining along airways of Super
p53, wild-type, and p53-deficient mice.
(G) Number of nuclei per unit area (n = 3).
BM and area are measured in pixels and square pixels,
respectively. Scale bars represent 20 mm in (A), 50 mm
in (D), and 10 mm in (F). *p < 0.05; **p < 0.01; ****p <
0.0001. All data shown represent mean ± SEM.
See also Figures S1 and S2.
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generate a basal-like cell in vitro, following p53 loss. Interestingly,
only about 40%of coloniescontainingp63-positivecells alsocon-
tained K5-positive cells, showing discordance between these two
basal cell markers in our in vitro system (Figures S3G and S3H).
Taken together, these data indicate that p53 loss alters the differ-
entiation potential of club cells in vitro (Figure 3L).
p53 Regulates the Proportion of Progenitors in the
Airway
To better understand the cellular and molecular mechanisms
driving p53-dependent regulation of progenitor cell fate, we
used single-cell RNA-seq. Lineage-tagged GFP+ cells from
tamoxifen-treated Scgb1a1-CreERTM; Rosa26-mT/mG mice
with a p53flox/flox or p53+/+ allele (p53D/D and p53+/+, respectively)
were sorted at day 70, and single-cell sequencing was per-
formed using a Fluidigm C1 system. After quality control and
normalization, transcriptomes of 64 p53+/+ and 64 p53D/D cells
were analyzed using principal-component analysis and an unsu-
pervised heatmap of the top 250 protein coding genes with the
highest expression variation across all cells (Figures S3I and
S3J). Surprisingly, clustering patterns observed in the prin-
cipal-component analysis and heatmap suggest that cellular
heterogeneity between Scgb1a1-lineage-labeled cells, rather
than p53 status, represent the principal determinants of molec-
ular variability (Figure 3M). We saw segregation between four
clusters of cells; each cluster containing variousmarkers of prox-
imal or distal club cell subtypes. p53 loss altered the proportion
of cells that fell in each cluster (Figure 3N).
Considering that p53 loss expanded differentiation potential
in vitro, RNA-seq data were mined for alterations in other pro-
genitor types. Bronchioalveolar stem cells (BASCs) are a contro-
versial progenitor type marked by the co-expression of Scgb1a1
and Sftpc and were proposed to generate both airway and alve-
olar cell types (Kim et al., 2005). We identified airway epithelial
cells (Sox2+) (Gontan et al., 2008) that express both Scgb1a1
and Sftpc, which increased in abundance when p53 was
lost (Figure 3O). Additionally, the number of lineage-labeled
Scgb1a1+Sftpc+ cells per terminal bronchiole is significantly
increased at 70 days post-tamoxifen in p53D/D mice, further
supporting the notion that p53 regulates multipotency of club
progenitors (Figures 3P and 3Q). These data show that p53
loss does not radically change the gene expression profile of
club progenitor cells but, instead, may regulate the proportions
of regionally distinct subtypes of progenitor cells within the
Scgb1a1-lineage-labeled population.
p53 Loss Increases the Number of Cycling Cells
To gain further insights into mechanisms by which p53 regulates
progenitor behavior, we analyzed pathways that were altered
in p53D/D cells using the DAVID online pathway analysis tool
(Huang et al., 2009a, 2009b). The most significantly enriched
pathway in p53D/D cells was cell cycle (Figure S4A). Expression
levels of genes frequently enriched in the G2/M cell-cycle phase
were increased in p53-deficient cells (Figure 4A). Both the total
number and expression levels of cell-cycle-promoting genes
were significantly increased in p53D/D cells (Figures 4B and
4C). Conversely, p53D/D cells expressed significantly reduced
levels of cell-cycle-inhibitor genes compared to p53-sufficientcells (Figures 4D and 4E). Notably, we found reduced expression
of the cell-cycle inhibitor p21 (Cdkn1a), whose expression is nor-
mally upregulated following stress-induced p53 activation (Fig-
ure S4E). As a control for random variability in gene expression
between genotypes, we evaluated the number of housekeeping
genes expressed in each cell and found no significant difference
between genotypes (Figure S4B). Finally, the expression of pro-
apoptotic genes was also significantly lower in p53D/D cells as
compared to control (Figures S4C and S4D). Additionally, we
performed RNA-seq on sorted GFP+ cells from Scgb1a1-
CreERTM; Rosa26-mT/mG; p53flox/flox or p53+/+ mice and verified
that the expression of p53 and traditional p53 pathwaymembers
decreased in p53D/D cells (Figure 4F). Together, these findings
reinforce the notion that p53 maintains quiescence of club pro-
genitor cells by regulating genes that are normally associated
with stress-activated p53 signaling.
p21 Regulates Proliferation, but Not Differentiation, of
Club Progenitors
To further explore roles for p21 as a downstream target of p53 in
regulating progenitor cell quiescence, we determined whether
p21 deletion phenocopied cell cycle and density phenotypes
observed with p53 loss of function. To assess proliferation,
the number of FACS-isolated epithelial cells from p21+/ and
p21/ mice in G2/M phase was measured by propidium iodide
(PI) staining. p21/mice, but not p21+/mice, contained signif-
icantly more cells in G2/M (Figures 4G and S4F). We quantified
the number of nuclei per unit basement membrane in p21+/
and p21/ mice and found that p21 loss resulted in increased
cell density in both genotypes compared to control (Figures 4H
and S4G). To determine whether p21 also regulates differentia-
tion, we quantified the percentage of FoxJ1-positive ciliated
cells in the airway epithelium. Interestingly, there was no signifi-
cant change in the number of ciliated cells in p21-deficient mice
(Figures 4I and S4H). These results suggest that quiescence, but
not differentiation, of club progenitor cells is regulated by p21
(Figure 4J). This finding partially phenocopies p53 loss of func-
tion and suggests that other p53 targets regulate differentiation
of club progenitor cells.
DISCUSSION
In this study, we demonstrate that p53 critically regulates pro-
genitor cell behavior to control cell density and composition in
airways. We use cell-type-specific p53 knockouts as well as
Super p53 mice to show that regulation of progenitor cell
behavior occurs in a gene dose-dependent manner. These
data illustrate that changes in baseline expression of p53 are
important determinants of progenitor cell fate.
Previous studies show that p53 regulates self-renewal and dif-
ferentiation of neural, mammary, hematopoietic, and nephron
stem and progenitor cells (Armesilla-Diaz et al., 2009; Cicalese
et al., 2009; Li et al., 2015; Liu et al., 2009; Meletis et al., 2006;
Tosoni et al., 2015). However, these previous studies have
been performed under conditions of rapid cell expansion
in vitro or during development. As such, these studies leave
gaps in our understanding of roles for p53 in regulating stem
and progenitor cells in quiescent tissues under homeostaticCell Reports 17, 2173–2182, November 22, 2016 2177
p53+/+ p53∆/-
0
5
10
15
Li
ne
ag
e 
Ta
gg
ed
 C
ol
on
ie
s
w
ith
 K
5 +
 C
el
l s
 (%
) *
GFP, FoxJ1, K5,
P
pro-Sftpc
GFP
Scgb1a1
pro-Sftpc, GFP, Scgb1a1, DAPI
p53∆/∆ GFP+Scgb1a1+Sftpc+ Cells   
2 70
0
1
2
3
4
5
G
FP
+ S
cg
b1
a1
+ S
ftp
c+
 c
el
ls
 p
er
 
te
rm
i n
al
 b
ro
nc
hi
ol
e 
(a
vg
 #
) p53+/+
p53∆/∆
ns
***
Days post-TMX 
Q
p53+/+ p53∆/-
0
5
10
15
Li
ne
ag
e 
Ta
gg
ed
 C
ol
on
ie
s 
w
it h
 C
ili
at
ed
 C
el
l s
 ( %
)
*
α-tub, GFP,
α-tub, K5,
G
J KH
I
A B C
GFP, RFP, FoxJ1, DAPI
0
10
20
30
40
50
60
p53+/+ Super p53
%
 F
ox
J1
+ 
ce
lls
****p53+/+
p53∆/-
Club
Ciliated
p53+/+
in vivo
Club
Ciliated
Basal
p53 Loss
in vivoin vitro
Ciliated
2 30 70
0
2
4
6
8
10
12
14
16
Days post-TMX
%
 F
ox
J1
+ 
lin
ea
ge
 ta
gg
ed
 c
el
ls
p53+/+
p53∆/-
p53∆/∆
****
****
****
****
D E
p5
3−
G
2−
1−
C3
8_
S2
9.
KO
p5
3−
H7
−1
−d
eb
ris
−C
46
_S
66
.K
O
A2
−1
−C
02
_S
2.
W
T
p5
3−
H2
−1
−C
44
_S
38
.K
O
p5
3−
B4
−1
−C
55
_S
56
.K
O
p5
3−
B6
−1
−C
57
_S
5.
K O
p5
3−
G
7−
1−
C4
0_
S5
8.
KO
p5
3−
G
3−
1−
C3
9_
S3
0.
K O
p5
3−
D1
2−
1−
C7
2_
S1
8.
K O
p5
3−
D5
−1
−C
68
_S
40
. K
O
p5
3−
A1
2−
1−
C5
4_
S6
1.
KO
p5
3−
O
ffC
hi
p−
Po
s−
Ct
r l_
S3
6.
KO
p5
3−
A8
−1
−C
05
_S
6.
KO
B5
−1
−C
56
_S
32
.W
T
p5
3−
D1
0−
1−
C7
0_
S2
6.
KO
G
8−
1−
C4
1_
S7
.W
T
C2
−1
−C
14
_S
21
.W
T
C9
−1
−C
16
_S
44
.W
T
E9
−1
−C
30
_S
62
.W
T
D
2−
1−
C2
0_
S3
0.
W
T
B7
−1
−C
12
_S
51
.W
T
B9
−1
−C
10
_S
35
.W
T
A1
0−
1−
C5
2_
S1
8.
W
T
B1
0−
1−
C5
8_
S2
7.
W
T
A1
1−
1−
C5
3_
S6
3.
W
T
A4
−1
−C
49
_S
58
.W
T
F8
−1
−d
eb
ris
v a
lve
−
C3
5_
S7
0.
W
T
H
7−
1−
C4
6_
S3
4.
W
T
p5
3−
D8
−1
−C
23
_S
33
.K
O
p5
3−
F5
−1
−C
80
_S
57
. K
O
p5
3−
C1
2−
1−
C6
6_
S9
.K
O
p5
3−
E6
−1
−1
va
lve
−
C7
3_
S2
3.
KO
p5
3−
C1
0−
1−
C6
4_
S1
7.
KO
p5
3−
H3
−1
−C
45
_S
39
.K
O
p5
3−
F3
−1
−C
33
_S
21
.K
O
p5
3−
B9
−1
−C
10
_S
7.
KO
p5
3−
F2
−1
−3
va
lve
−
C3
2_
S2
0.
K O
p5
3−
D2
−1
−C
20
_S
2.
KO
A6
−1
−C
51
_S
59
.W
T
p5
3−
G
8−
1−
C4
1_
S5
9.
KO
p5
3−
A6
−1
−C
51
_S
65
.K
O
p5
3−
E9
−1
−C
30
_S
34
.K
O
H
1−
1−
C4
3_
S6
5.
W
T
p5
3−
G
4−
1−
C8
7_
S1
3.
KO
p5
3−
G
9−
1−
C4
2_
S5
2.
KO
p5
3−
H1
−1
−C
43
_S
46
.K
O
p5
3−
D3
−1
−C
19
_S
3.
KO
p5
3−
D9
−1
−C
22
_S
25
.K
O
p5
3−
A1
−1
−C
03
_S
1.
KO
A9
−1
−C
04
_S
26
.W
T
G
1−
1−
C3
7_
S5
6.
W
T
C8
−1
−C
17
_S
52
.W
T
F7
−1
−C
34
_S
16
.W
T
C1
−1
−C
15
_S
20
.W
T
A1
2−
1−
C5
4_
S2
8.
W
T
D
6−
1−
C6
9_
S1
5.
W
T
E1
2−
1−
C7
6_
S5
5.
W
T
B1
2−
1−
C6
0_
S3
7.
W
T
H
8−
1−
C4
7_
S1
7.
W
T
A5
−1
−C
50
_S
23
.W
T
D
7−
1−
C2
4_
S6
9.
W
T
B1
−1
−C
09
_S
11
.W
T
E6
−1
−C
73
_S
24
.W
T
A7
−1
−C
06
_S
42
.W
T
B2
−1
−C
08
_S
12
.W
T
B4
−1
−C
55
_S
67
.W
T
D
10
−1
−C
70
_S
36
.W
T
E2
−1
−C
26
_S
39
.W
T
B6
−1
−C
57
_S
68
.W
T
F9
−1
−C
36
_S
71
.W
T
B1
1−
1−
C5
9_
S7
2.
W
T
D
1−
1−
C2
1_
S2
9.
W
T
G
9−
1−
C4
2_
S8
.W
T
A3
−1
−C
01
_S
3.
W
T
E1
−1
−C
25
_S
38
.W
T
p5
3−
B1
0−
1−
C5
8_
S8
.K
O
F1
−1
−C
31
_S
47
.W
T
p5
3−
C2
−1
−C
14
_S
62
.K
O
G
3−
1−
C3
9_
S4
0.
W
T
H
3−
1−
C4
5_
S4
9.
W
T
p5
3−
D1
1−
1−
C7
1_
S5
3.
K O
p5
3−
B7
−1
−C
12
_S
32
.K
O
p5
3−
E1
2−
1−
C7
6_
S2
7.
KO
G
2−
1−
C3
8_
S5
7.
W
T
B8
−1
−C
11
_S
43
.W
T
E3
−1
−C
27
_S
22
.W
T
F6
−1
−C
79
_S
33
.W
T
p5
3−
B3
−1
−C
07
_S
55
. K
O
p5
3−
B1
−1
−C
09
_S
10
.K
O
p5
3−
C1
−1
−C
15
_S
19
.K
O
p5
3−
C1
1−
1−
C6
5_
S4
4.
K O
p5
3−
B1
1−
1−
C5
9_
S3
5.
KO
G
12
−1
−C
88
_S
73
.W
T
p5
3−
C9
−1
−C
16
_S
16
.K
O
p5
3−
A4
−1
−C
49
_S
48
.K
O
p5
3−
E1
−1
−C
25
_S
37
.K
O
F2
−1
−C
32
_S
48
.W
T
H
12
−1
−C
94
_S
10
.W
T
F1
1−
1−
C8
3_
S1
9.
W
T
p5
3−
D4
−1
−C
67
_S
4.
KO
p5
3−
C7
−1
−C
18
_S
41
.K
O
D
11
−1
−C
71
_S
9.
W
T
p5
3−
E8
−1
−C
29
_S
42
.K
O
p5
3−
D1
−1
−C
21
_S
28
.K
O
p5
3−
E3
−1
−C
27
_S
12
.K
O
p5
3−
C4
−1
−C
61
_S
64
.K
O
p5
3−
B2
−1
−C
08
_S
54
.K
O
C3
−1
−C
13
_S
13
.W
T
p5
3−
C3
−1
−C
13
_S
63
. K
O
p5
3−
C8
−1
−C
17
_S
24
.K
O
p5
3−
H8
−1
−C
47
_S
67
.K
O
p5
3−
E5
−1
−C
74
_S
49
.K
O
E8
−1
−C
29
_S
61
.W
T
D
9−
1−
C2
2_
S5
3.
W
T
p5
3−
B5
−1
−C
56
_S
22
.K
O
p5
3−
A3
−1
−C
01
_S
47
. K
O
F3
−1
−C
33
_S
31
.W
T
p5
3−
F8
−1
−C
35
_S
51
.K
O
C7
−1
−C
18
_S
60
.W
T
p5
3−
F9
−1
−C
36
_S
43
.K
O
p5
3−
H9
−1
−C
48
_S
60
.K
O
p5
3−
E2
−1
−C
26
_S
11
.K
O
p5
3−
B8
−1
−C
11
_S
15
.K
O
p5
3−
C5
−1
−C
62
_S
31
.K
O
C1
2−
1−
C6
6_
S4
6.
W
T
E7
−1
−C
28
_S
6.
W
T
A1
−1
−C
03
_S
1.
W
T
H
2−
1−
C4
4_
S6
6.
W
T
Sftpc
Etv5
Nkx2−1
Krt8
Cyp2f2
Scgb1a1
Scgb3a2
Sox2
Muc5ac
Sox9
Pdpn
Reg3g
Scgb3a1
Foxj1
−2 −1 0 1 2
Value
p53∆/∆
p53+/+
0
20
40
60
80
100
p53+/+ p53∆/- p53∆/∆
%
 S
cg
b1
a1
+ 
lin
ea
ge
 
ta
gg
ed
 c
el
ls
** ***
0
25
50
75
p53+/+ Super p53
%
 S
cg
b1
a1
+ 
ce
lls **
F
M
p53+/+
p53∆/∆
Cluster 1
Cluster 2
Cluster 3
Cluster 4
N O
p53+/+ p53∆/∆
0
5
10
15
20
So
x2
+ S
cg
b1
a1
+ S
ftp
c+
 c
el
ls
 (%
) 
L
1 2 3 4
α-tub, GFP,
p53+/+
p53∆/-
p53∆/-
Club
in vitro
Color Key
(legend on next page)
2178 Cell Reports 17, 2173–2182, November 22, 2016
conditions. Our finding that p53 controls quiescence and differ-
entiation in the homeostatic lung provides key insights into pro-
genitor cell regulation and complements previously published
results.
We show that an extra copy of p53 promoted ciliated cell dif-
ferentiation and decreased proliferation, leading to decreased
epithelial cell density. Furthermore, we found a dose-dependent
effect on p53 levels in the ability of club progenitors to clonally
expand. This demonstrates that tight control of p53 is essential
to maintain the proper number of progenitor cells that contribute
to epithelial maintenance under homeostatic conditions. Precise
regulation of secretory-to-ciliated cell ratios is essential for effec-
tive mucociliary clearance and host defense.
Surprisingly, club cells with p53 loss showed altered differen-
tiation potential in vitro, yielding organoids composed of a
pseudostratified epithelium containing ciliated cells as well as
p63- and K5-expressing basal-like cells. Previous reports have
described the dedifferentiation of club cells to basal cells
following basal cell deletion and Yap overexpression, indicating
that club cells have an inherent plasticity that is suppressed un-
der homeostatic conditions (Tata et al., 2013; Zhao et al., 2014).
In contrast to these findings, we never observed lineage-labeled
basal cells in vivo. However, our in vitro data indicate that the
differentiation potential of club cells is suppressed by both
p53-dependent cell-autonomous and microenvironmental fac-
tors. Furthermore, organoids derived from p53-deficient club
cells included p63-positive epithelial cells that were negative
for K5. Organoids containing p63+ K5 epithelial cells were
also observed following culture of p53-sufficient club cells, but
with a significantly lower frequency than observed following cul-
ture of p53-deficient club cells. Discordance in p63 and K5
expression may reflect immaturity and the relatively high rate
of cell proliferation among basal cells derived from p53-deficient
club cells. The finding that ciliated cells were only observed in
association with K5-positive cells and that the appearance ofFigure 3. p53 Regulates Differentiation
(A) Immunofluorescent (IF) staining for confetti-lineage tag (nuclear GFP, cytopla
indicated in red) and FoxJ1 in white in Scgb1a1-CreERTM; Rosa26R-Confetti; p5
(B) Quantification of the percentage of FoxJ1-positive confetti-lineage-tagged ce
p53D/D, respectively) at 2, 30, and 70 days post-tamoxifen (post-TMX) (n = 3–4).
(C) Quantification of the percentage of FoxJ1-positive nuclei out of total nuclei in
(D) Percentage of Scgb1a1-positive confetti-lineage-tagged cells inScgb1a1-Cre
at 70 days post-tamoxifen (n = 3).
(E) Percentage of Scgb1a1-positive cells out of total airway epithelial cells in Sup
(F and G) IF of a p53+/+ (F) or p53D/ (G) colony with GFP (red) and a-tubulin to v
(H) IF staining of basal cell marker K5 (red), ciliated cell marker FoxJ1 (green), an
(I) IF staining of basal cell marker K5 (red) and a-tubulin to visualize cilia (green).
(J and K) Percentage of lineage-tagged colonies containing K5-positive cells (J)
(L) p53 controls ciliated-cell differentiation in vivo and differentiation potential in
(M) Unsupervised heatmap showing cell-subtype-specific genes, segregated by
(N) Pie chart depicting the percentage of cells that fall into the four clusters in (M
(O) Percentage of single cells that co-express Sox2, Scgb1a1, and Sftpc.
(P) Immunostaining for Sftpc in red, Scgb1a1 in green, and GFP in white in S
Arrowheads indicate co-expressing cells; a dashed line is shown at the baseme
(Q) Number of lineage-tagged Scgb1a1+Sftpc+ cells per terminal bronchiole in Sc
tamoxifen (TMX). avg, average.
DAPI is indicated in blue. n = 64 cells per genotype for (M)–(O). Scale bars repre
**p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant. All data shown repres
See also Figure S3.K5-positive cells preceded that of ciliated cells (data not shown),
suggests that ciliated cells are basal cell derived and that basal-
to-ciliated cell differentiation is not influenced by p53 status.
These data are in contrast to observations in vivo, wherein p53
deficiency promoted club cell renewal in preference to ciliated
cell differentiation.
Scgb1a1-expressing cells were previously thought to be a
relatively uniform pool of quiescent progenitors (Rawlins et al.,
2009). However, using single-cell RNA-seq, we observed
heterogeneity between various subtypes of cells within the
Scgb1a1-lineage-labeled population. We identified lineage-
traced cells that co-expressed Scgb1a1 and Sftpc, the molecu-
lar phenotype described for putative BASCs. Furthermore, the
number of Scgb1a1+Sftpc+ cells increased with p53 loss, impli-
cating p53 as a regulator of this progenitor state. However, the
functional role of these progenitor cells in repairing the airway
and alveoli has yet to be determined. The potential for p53 loss
to expand the pool of ‘‘active’’ progenitors was supported by
the observation of an increase in the number of cycling cells
and a decrease in cell-cycle inhibitors, particularly p21, following
p53 loss. Mice with germline loss of p21 function phenocopied
effects of conditional p53 loss on epithelial cell proliferation,
but not differentiation. Even though we cannot exclude the
potential for non-cell-autonomous effects of germline p21 defi-
ciency, these results support the notion that proliferation and dif-
ferentiation in club cells are regulated by distinct downstream
targets of p53. Candidate pathways that maymediate the effects
of p53 on cellular differentiation include Notch, a known target
of p53 and a pathway that has been shown to modulate club-
to-ciliated-cell transdifferentiation (Lafkas et al., 2015).
Recent literature has demonstrated that cancers often arise
from resident stemor progenitor cells (Blanpain, 2013; Tomasetti
and Vogelstein, 2015). Here, we show that the loss of a tumor
suppressor leads to an increase in self-renewal and proliferation
of progenitor cells. These conditions could lead to preneoplasticsmic YFP, and membrane CFP are indicated in green, and cytoplasmic RFP is
3+/+ or p53D/ mice at 70 days post-tamoxifen.
lls in Scgb1a1-CreERTM; Rosa26R-Confetti; p53D/ or p53D/D mice (p53D/ or
the airway epithelium in Super p53 mice (n = 3).
ERTM; Rosa26R-Confetti; p53D/ or p53D/Dmice (p53D/ or p53D/D, respectively)
er p53 mice (n = 3–4).
isualize cilia (green).
d GFP (white).
or ciliated cells (K) (n = 3).
vitro.
four secondary clades (clusters).
).
cgb1a1-CreERTM; Rosa26-mT/mG; p53D/D mice at 70 days post-tamoxifen.
nt membrane.
gb1a1-CreERTM; Rosa26-mT/mG; p53+/+ or p53D/Dmice at 2 or 70 days post-
sent 10 mm in (A), (H), and (P); 20 mm in (I); and 50 mm in (F) and (G). *p < 0.05;
ent mean ± SEM.
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Figure 4. p53-Deficient Progenitors Have IncreasedCell-Cycle Progression andDecreased Cell-Cycle Inhibition in a p21-DependentManner
(A) Supervised heatmap showing cell-cycle-promoting genes, which have higher expression in p53-deficient cells.
(B) Expression of cell-cycle-promoting genes is significantly higher when p53 is lost. *p = 0.0157, two-way ANOVA.
(C) Scatterplot depicting the total number of cell-cycle promoters expressed (Log2(transcripts per million reads [TPM]) > 1) per cell.
(D) Expression of cell-cycle inhibitors are lower when p53 is lost.
(E) Scatterplot depicting the number of cell-cycle inhibition genes expressed (Log2(TPM) > 1) per cell.
(F) Unsupervised heatmap showing p53 pathway genes obtained from population RNA-seq performed on isolated Scgb1a1-lineage-labeled cells from Scgb1a1-
CreERTM; Rosa26-mT/mG; p53+/+ or p53D/D mice (p53+/+ or p53D/D, respectively) (n = 3).
(G) Percent total isolated epithelial cells from p21 knockout mice in G2/M relative to control (n = 3).
(H) Number of nuclei per unit basement membrane in the airway epithelium of p21 knockout mice (n = 3).
(I) Percent FoxJ1-positive nuclei in the airway epithelium of p21 knockout mice (n = 3).
(J) p53 controls proliferation and density through p21.
*p < 0.05; **p < 0.01; ****p < 0.0001; ns, not significant. All data shown represent mean ± SEM.
See also Figure S4.lesions, either alone or in combination with additional injuries or
mutations. Interestingly, a high number of p53 copies in ele-
phants has been correlated with a lower cancer risk (Abegglen2180 Cell Reports 17, 2173–2182, November 22, 2016et al., 2015; Sulak et al., 2015). We discovered that an additional
copy of p53 reduced the proliferation rate and increased terminal
differentiation, both of which likely promote tumor suppression.
Together, our data demonstrate that p53 plays an essential role
as a tumor suppressor by regulating progenitor cell behavior in
the lung.
EXPERIMENTAL PROCEDURES
Mice
Scgb1a1-CreERTM; Rosa26-mT/mG and Scgb1a1-CreERTM; Rosa26R-
Confetti mice were previously described (Farin et al., 2015). These mice
were crossed to p53flox mice (The Jackson Laboratory, stock number
008462), p53/ mice (The Jackson Laboratory, stock number 002101), or
Super p53 tg mice (Garcı´a-Cao et al., 2002), which were provided by Manuel
Serrano, to generate experimental animals. Detailed explanation of mouse
strains are in the Supplemental Experimental Procedures. Mice were injected
with tamoxifen in corn oil: 33 200 mg/kg (body weight), 13 250 mg/kg (body
weight), or 1 3 5 mg/kg (body weight) for high-dose, RNA-seq, and low-dose
experiments, respectively. All mice were maintained and treatments were
carried out according to IACUC (Institutional Animal Care and Use Commit-
tee)-approved protocols.
Immunofluorescence Staining, Imaging, and Quantification
Immunofluorescence imaging was performed on fixed lung tissue embedded
in paraffin and processed as previously described (Chen et al., 2012). The
antibodies used, imaging, and quantification details are given in the Supple-
mental Experimental Procedures.
Cell-Cycle Analysis
Airway epithelial cells (EpCAM+, CD31/34/45, and 7AAD) were sorted using
a MoFlo XDP cell sorter (Beckman Coulter), fixed with 70% ice-cold ethanol,
treated with RNase A (19101, QIAGEN), and stained with PI (P4170, Sigma).
The Supplemental Experimental Procedures detail the BrdU treatment and
analysis. Stained cells were analyzed on an LSRFortessa (BD Biosciences)
flow cytometer.
In Vitro Sultures
Airway epithelial cell isolation and flow cytometry were performed as
previously described (Farin et al., 2015). The Supplemental Experimental
Procedures contain details regarding culture conditions and serial passaging.
Colony-forming efficiency was performed after 7 days in vitro, and immuno-
fluorescence analysis was performed after 14 days in vitro.
RNA-Seq
Details on single-cell and population RNA-seq methodology and analysis are
provided in the Supplemental Experimental Procedures.
Statistical Analysis
Data were analyzed and compared between groups using a two-tailed, un-
paired Student’s t test, a one-way ANOVA, or a two-way ANOVA with post
hoc analysis (Prism, GraphPad). A p < 0.05 was considered statistically signif-
icant and is presented as *p < 0.05, **p < 0.01, ***p < 0.001, or ****p < 0.0001.
ACCESSION NUMBERS
The accession number for the single-cell and population RNA-seq data re-
ported in this paper is GEO: GSE78045.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.11.007.
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